Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human PMEL Polyclonal Antibody

Catalog #:   PHE28701 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P40967
Overview

Catalog No.

PHE28701

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human PMEL (Gln65-Thr299).

Applications

ELISA, IHC, WB

Recommended Dilution

Application Dilution
ELISA 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

ME20M, Melanocyte protein PMEL, Silver locus protein homolog, Secreted melanoma-associated ME20 antigen, D12S53E, 95 kDa melanocyte-specific secreted glycoprotein, SILV, P100, Premelanosome protein, PMEL17, ME20S, PMEL, ME20-S, ME20-M, P26, P1, Melanocytes lineage-specific antigen GP100, Melanocyte protein Pmel 17, Melanoma-associated ME20 antigen

Purification

Purified by antigen affinity column.

Accession

P40967

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Note

For research use only.

Data Image
  • WESTERN-BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with PMEL antibody (PHE28701) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 28 kDa
    Observed MW: 28 kDa
  • Western Blot
    Various lysates were subjected to SDS PAGE followed by western blot with PMEL antibody (PHE28701) at 1 μg/ml.

    Lane 1: Rat heart
    Lane 2: Mouse heart

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 70 kDa
    Observed MW: 70 kDa
  • Immunohistochemical
    Immunohistochemical analysis of human skin tissue stained for PMEL with PHE28701.
References

Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer., PMID:20631075

The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis., PMID:21962903

The use of immunocytochemical study in the cytologic diagnosis of melanoma: evaluation of three antibodies., PMID:22021247

Primary oral melanoma: a histopathological and immunohistochemical study of 22 cases of Latin America., PMID:22143732

Epithelioid angiosarcoma of bone and soft tissue: a report of seven cases with emphasis on morphologic diversity, immunohistochemical features and clinical outcome., PMID:22158488

Aberrant expression of HMB-45 in traumatized melanocytic nevi., PMID:22285619

A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin., PMID:22297636

Perivascular epithelioid cell tumor (PEComa) of gynecologic origin: a clinicopathological study of three cases., PMID:22439417

The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanoma., PMID:22613716

Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy., PMID:22972494

Metastatic melanoma presenting as an isolated breast tumor: a study of 20 cases with emphasis on several primary mimickers., PMID:23276173

A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity., PMID:23333935

[Detection of serum autoantibodies against premelanosome protein 17 increases in the vitiligo patients]., PMID:23643172

Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update., PMID:23648379

Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas., PMID:23899062

Cytotoxic T lymphocyte antigen-4 blockade enhances antitumor immunity by stimulating melanoma-specific T-cell motility., PMID:25038199

A monoclonal antibody against PMEL., PMID:25118787

Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFNγ-dependent cell-cycle arrest., PMID:25127875

Hyperosmotic stress reduces melanin production by altering melanosome formation., PMID:25170965

Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules., PMID:25411763

Metastatic melanoma of the tongue: a case report with immunohistochemical profile., PMID:25427453

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma., PMID:25787767

Hashimoto's thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases., PMID:27020052

Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection., PMID:27193292

Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects., PMID:27267778

Increased Activity and Number of Epidermal Melanocytes in Lesional Psoriatic Skin., PMID:27497917

The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas., PMID:28123877

Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures., PMID:28288506

Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment., PMID:28851824

Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver., PMID:29122287

ABCB6 Resides in Melanosomes and Regulates Early Steps of Melanogenesis Required for PMEL Amyloid Matrix Formation., PMID:29940187

Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors., PMID:31351802

Optimizing T-cell receptor avidity with somatic hypermutation., PMID:31381134

PNL2: A Useful Adjunct Biomarker to HMB45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa)., PMID:31851063

CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: A cautionary (and molecularly annotated) tale., PMID:31943331

SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint., PMID:32122464

Indication of Premelanosome Protein (PMEL) Expression Outside of Pigmented Bovine Skin Suggests Functions Beyond Eumelanogenesis., PMID:32668786

Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes., PMID:32817208

Autoimmune response against tyrosinase induces depigmentation in C57BL/6 black mice., PMID:33084421

Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab: A case report., PMID:33327228

Dry Formulation of Virus-Like Particles in Electrospun Nanofibers., PMID:33802376

CCL17-CCR4 axis contributes to the onset of vitiligo in mice., PMID:34077992

Adiponectin negatively regulates pigmentation, Wnt/β-catenin and HGF/c-Met signalling within human scalp hair follicles ex vivo., PMID:34854998

Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD., PMID:35473441

Requirements for anti-aquaporin 5 autoantibody production in a mouse model., PMID:37718989

β-Catenin in Dendritic Cells Negatively Regulates CD8 T Cell Immune Responses through the Immune Checkpoint Molecule Tim-3., PMID:38793711

PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors., PMID:38916203

In Situ Protein Expression Analysis of Melanocyte Differentiation Antigen TRP1 (Tyrosinase-Related Protein-1)., PMID:39008470

[Clinicopathological features of metastatic melanoma in effusion cytology of serosal cavity]., PMID:39103266

CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors., PMID:39805660

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human PMEL Polyclonal Antibody [PHE28701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only